Trials / Completed
CompletedNCT04500132
To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia
Phase 2, Multi-center, Randomized, Double-blind, Placebo- Controlled Study to Evaluate the Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 63 (actual)
- Sponsor
- Enzychem Lifesciences Corporation · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
Prevention of COVID-19 infection to severe pneumonea or ARDS
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | EC-18 | EC-18 QD |
| DRUG | Placebo EC-18 | Placebo EC-18 QD |
Timeline
- Start date
- 2020-05-28
- Primary completion
- 2021-02-04
- Completion
- 2021-02-15
- First posted
- 2020-08-05
- Last updated
- 2022-02-10
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04500132. Inclusion in this directory is not an endorsement.